Treatment of Cardiac Autonomic Neuropathy
Publisher
Springer Singapore
Reference24 articles.
1. Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G. Effects of treatment with the antioxidant on cardiac autonomic neuropathy in NIDDM patients: a 4-month randomized controlled multicenter trial, Deutsche Kardiale Autonome Neuropathie. Diabetes Care. 1997;20(3):369–73. [PMID: 9051389].
https://doi.org/10.2337/diacare.20.3.369
.
2. Manzella D, Barbieri M, Ragno E, Paolisso G. Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes. Am J Clin Nutr. 2001;73:1052–7.
3. Pop-Busui R, Stevens MJ, Raffel DM, et al. Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomized controlled trial. Diabetologia. 2013;56(8):1835–44.
4. Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27(7):639–53.
5. Hu X, Li S, Yang G, Liu H, Boden G, Li L. Efficacy and safety of aldose Reductase inhibitor for the treatment of diabetic cardiovascular autonomic neuropathy: systematic review and meta-analysis. PLoS One. 2014;9(2):e87096.